Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

for the CREDENCE Trial Investigators

Research output: Contribution to journalArticle

739 Scopus citations

Fingerprint Dive into the research topics of 'Canagliflozin and renal outcomes in type 2 diabetes and nephropathy'. Together they form a unique fingerprint.

Medicine & Life Sciences